Martínez Candela J, Gallardo Martín A, Franch Nadal J, Romero Ortiz J, Cánovas Domínguez C, Gómez Marco R
Unidad Docente Medicina Familiar y Comunitaria y Gerencia, Atención Primaria Murcia, Centro Salud Mariano Yago, Yecla, Murcia, Spain.
Aten Primaria. 2004 Oct 31;34(7):345-52. doi: 10.1016/s0212-6567(04)79514-1.
To determine the prevalence of impaired fasting glucose (IFG or GBA), impaired glucose tolerance (IGT) and type 2 diabetes mellitus (DM2) in the adult population of Yecla. RESEARCH, DESIGN, AND METHODS: We performed a population-based cross-sectional study (on Primary Care Field) with stratified and random sampling (393) from 17 500 residents in Yecla with sanitary card and aged > or =30 years. We studied 286 subjects (107 declining to participate) and 261 of them (125 men and 136 women) underwent an oral glucose tolerance test (OGTT).
World Health Organization (WHO-99) and American Diabetes Association (ADA-97) criteria were used for diagnosis of unknown DM2, GBA and IGT. Socio-demographic and anthropometric variables were measured. Plasma lipid, glycosylated haemoglobin (HbA1C), microalbuminuria and insulin levels also were measured. Insulin resistance was evaluated by the HOMA method.
According ADA-97 criteria the prevalence of DM2 and GBA was 2.65 (CI+/-1.95) and 4.3% (+/-2.5) respectively. Underwent an OGTT, the age-adjusted prevalence of DM2, IGT and GBA (using the Spanish population of July 02) was 6.7 (95%CI, 3,7-9,7); 13.2 (95%CI, 9.1-17.3) and 0.2% (95%CI, 0-1.8) respectively. The known DM2 was 5,9% (95%CI, 3.8-8) and the global prevalence of DM2 was 12.6% (95%CI, 9.6-15.6). The diabetes was associated with overweight, overage and higher insulin, HbA1C and insulin resistance levels.
There is a high prevalence of DM2 in Yecla (known/unknown 0.87/1). The ADA97 criteria only detected 53% of the unknown DM2. The 78% of normoglycemics subjects had overweight or upper-body fat distribution and diabetics people had higher BMI (Body Mass Index), Hypertension, insulinemia, HbA1C and insulin resistance levels than normoglycemics and IGT subjects.
确定耶克拉成年人群中空腹血糖受损(IFG或GBA)、糖耐量受损(IGT)和2型糖尿病(DM2)的患病率。研究、设计与方法:我们在初级保健领域开展了一项基于人群的横断面研究,对耶克拉17500名持有健康卡且年龄≥30岁的居民进行分层随机抽样(393人)。我们研究了286名受试者(107人拒绝参与),其中261人(125名男性和136名女性)接受了口服葡萄糖耐量试验(OGTT)。
采用世界卫生组织(WHO - 99)和美国糖尿病协会(ADA - 97)的标准诊断未确诊的DM2、GBA和IGT。测量社会人口统计学和人体测量学变量。还测量了血浆脂质、糖化血红蛋白(HbA1C)、微量白蛋白尿和胰岛素水平。通过HOMA方法评估胰岛素抵抗。
根据ADA - 97标准,DM2和GBA的患病率分别为2.65(CI±1.95)和4.3%(±2.5)。接受OGTT检查的人群中,经年龄调整后的DM2、IGT和GBA患病率(采用2002年7月的西班牙人群数据)分别为6.7(95%CI,3.7 - 9.7);13.2(95%CI,9.1 - 17.3)和0.2%(95%CI,0 - 1.8)。已知DM2患病率为5.9%(95%CI,3.8 - 8),DM2的总体患病率为12.6%(95%CI,9.6 - 15.6)。糖尿病与超重、年龄偏大以及较高的胰岛素、HbA1C和胰岛素抵抗水平相关。
耶克拉DM2的患病率较高(已知/未知为0.87/1)。ADA97标准仅检测出53%的未确诊DM2。78%血糖正常的受试者存在超重或上身脂肪分布,糖尿病患者的体重指数(BMI)、高血压、胰岛素血症、HbA1C和胰岛素抵抗水平高于血糖正常者和IGT受试者。